Page last updated: 2024-12-05

1-naphthaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Naphthaldehyde, also known as α-naphthaldehyde, is an organic compound with the formula C₁₁H₈O. It is a colorless to pale yellow liquid with a strong, pungent odor.

**Structure and Properties:**

* **Structure:** It consists of a naphthalene ring with an aldehyde group (-CHO) attached at the 1-position.
* **Physical Properties:** It is a liquid at room temperature, soluble in organic solvents like ethanol and ether, but poorly soluble in water.
* **Chemical Properties:** It is a reactive compound, capable of undergoing various chemical reactions like oxidation, reduction, and nucleophilic addition.

**Importance in Research:**

1-Naphthaldehyde is a valuable starting material and intermediate in various chemical and pharmaceutical research areas, including:

* **Synthesis of Pharmaceuticals:** It serves as a precursor in the synthesis of numerous pharmaceutical compounds, including anti-inflammatory drugs, antimicrobials, and anti-cancer agents.
* **Organic Synthesis:** It is employed in the synthesis of other organic compounds, like dyes, fragrances, and polymers.
* **Material Science:** 1-Naphthaldehyde derivatives are used in the development of advanced materials, such as conductive polymers and organic light-emitting diodes (OLEDs).
* **Biological Studies:** It is used as a probe in biological studies to investigate enzyme activity and cellular processes.
* **Chemical Catalysis:** It serves as a ligand in various catalytic reactions, promoting the formation of desired products.

**Applications:**

* **Dyeing and Printing:** Its derivatives are used as dyes and pigments in textiles and printing inks.
* **Flavoring and Perfumery:** It contributes to the aroma of certain perfumes and flavors.
* **Polymer Science:** It is used in the synthesis of polymers with specific properties, like conductivity or light emission.

**Safety Considerations:**

1-Naphthaldehyde is a potentially hazardous chemical. It is irritating to the skin, eyes, and respiratory system. Proper handling and protective measures should be taken when working with this compound.

**In summary,** 1-Naphthaldehyde is a versatile compound with significant applications in research, synthesis, and industrial processes. Its unique chemical structure and reactivity make it a valuable tool in developing new pharmaceuticals, materials, and technologies.

1-naphthaldehyde: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

naphthaldehyde : An aldehyde in which the organyl group is a naphthyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

1-naphthaldehyde : A naphthaldehyde with a formyl group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6195
CHEMBL ID3265260
CHEBI ID52367
SCHEMBL ID9005
MeSH IDM0054900

Synonyms (81)

Synonym
BIDD:GT0176
1-naphthalenecarboxaldehyde
nsc-6106
.alpha.-naphthal
1-formylnaphthalene
.alpha.-naphthaldehyde
66-77-3
nsc6106
1-naphthaldehyde
.alpha.-naphthylcarboxaldehyde
.alpha.-naphthylaldehyde
1-naphthylaldehyde
naphthaldehyde
naphthalene-1-carbaldehyde
i-napthaldehyde
nsc 6106
alpha-naphthylaldehyde
alpha-naphthaldehyde
alpha-naphthylcarboxaldehyde
alpha-naphthal
einecs 200-633-4
brn 0386082
inchi=1/c11h8o/c12-8-10-6-3-5-9-4-1-2-7-11(9)10/h1-8
1-naphthaldehyde, 95%
CHEBI:52367 ,
alphaalpha-naphthaldehyde
STK498756
AC-5796
AKOS000118888
BMSE000532
naphthalenecarboxaldehyde
N0002
chembl3265260 ,
bdbm50013801
A835544
unii-h3i0b5f8sx
h3i0b5f8sx ,
1-napthaldehyde
AM62619
a-naphthal
a-naphthaldehyde
30678-61-6
FT-0672609
FT-0608101
AB01331896-02
SCHEMBL9005
1-naphthylcarboxaldehyde
4-naphthalene-1-carboxaldehyde
DTXSID5058775
1naphthaldehyde
alpha-naphthoaldehyde
1-naphthalencarboxaldehyde
1-naphthalenecarbaldehyde
1-naphtoaldehyde
1-naphthoaldehyde
naphthal
naphthalene-formaldehyde
naphthalene-1 carbaldehyde
1-napthylaldehyde
naphthaleneformaldehyde
1-naphtaldehyde
naphthalene-1-aldehyde
naphthalene-1-carboxaldehyde
naphthaline-1-carbaldehyde
formylnaphthalene
W-104738
mfcd00004003
F2190-0608
CS-D1451
NCGC00341016-01
Q21050985
AS-19333
.alpha.-naphthoaldehyde
.alpha.-naphthalenecarboxaldehyde
1-formylnaphthalene; 1-naphthylaldehyde; 1-naphthylcarboxaldehyde
D70897
1-naphthyl aldehyde
naphtalene-1-carbaldehyde
EN300-19124
Z104472874
PD139181
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
naphthaldehydeAn aldehyde in which the organyl group is a naphthyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Single-stranded DNA cytosine deaminaseHomo sapiens (human)Potency56.234128.183860.145389.1251AID1347430
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)IC50 (µMol)20.00000.04532.28609.9390AID1140864
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
endothelial cell proliferationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mRNA catabolic processSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
regulation of macroautophagySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of RNA splicingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to unfolded proteinSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
response to endoplasmic reticulum stressSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
peptidyl-serine autophosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
IRE1-mediated unfolded protein responseSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of JUN kinase activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mRNA splicing, via endonucleolytic cleavage and ligationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to hydrogen peroxideSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to glucose stimulusSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of endoplasmic reticulum unfolded protein responseSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
insulin metabolic processSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
peptidyl-serine trans-autophosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mRNA processingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
cytidine deaminationSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
somatic diversification of immunoglobulinsSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
somatic hypermutation of immunoglobulin genesSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
B cell differentiationSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
regulation of nuclear cell cycle DNA replicationSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
defense response to bacteriumSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
positive regulation of gene expression via chromosomal CpG island demethylationSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
isotype switchingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
cellular response to lipopolysaccharideSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
DNA cytosine deaminationSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
DNA demethylationSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
cytidine to uridine editingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
negative regulation of single stranded viral RNA replication via double stranded DNA intermediateSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
defense response to virusSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
magnesium ion bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
RNA endonuclease activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
platelet-derived growth factor receptor bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
enzyme bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
Hsp70 protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
identical protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein homodimerization activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
ADP bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
Hsp90 protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
unfolded protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cytidine deaminase activitySingle-stranded DNA cytosine deaminaseHomo sapiens (human)
protein bindingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
zinc ion bindingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
ubiquitin protein ligase bindingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
identical protein bindingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
RNA bindingSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
nuclear inner membraneSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mitochondrionSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
endoplasmic reticulumSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
endoplasmic reticulum membraneSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
Ire1 complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
AIP1-IRE1 complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
IRE1-TRAF2-ASK1 complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
IRE1-RACK1-PP2A complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
nucleusSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
cytoplasmSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
cytosolSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
protein-containing complexSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
nucleusSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
cytoplasmSingle-stranded DNA cytosine deaminaseHomo sapiens (human)
P-bodySingle-stranded DNA cytosine deaminaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1656235Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability2019European journal of medicinal chemistry, Feb-15, Volume: 164Green recipes to quinoline: A review.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
AID1140864Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay2014Journal of medicinal chemistry, May-22, Volume: 57, Issue:10
Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity.
AID1602658Inhibition of mouse GAT-1 assessed as percentage of remaining specific binding of NO711 at 1 uM after 4 hrs by LC-ESI-MS/ms analysis relative to control2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's8 (61.54)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.24 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index56.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]